Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
1,273,954
-
Share change
-
-256,608
-
Total reported value
-
$1,718,330
-
Price per share
-
$1.35
-
Number of holders
-
19
-
Value change
-
-$332,918
-
Number of buys
-
10
-
Number of sells
-
6
Institutional Holders of VASCULAR BIOGENICS LTD - COM (VBLT) as of Q1 2020
As of 31 Mar 2020,
VASCULAR BIOGENICS LTD - COM (VBLT) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,273,954 shares.
The largest 10 holders included
MORGAN STANLEY, MACQUARIE GROUP LTD, CVI Holdings, LLC, RENAISSANCE TECHNOLOGIES LLC, ATHENA CAPITAL ADVISORS LLC, PVG ASSET MANAGEMENT CORP, Advisor Group Holdings, Inc., ENVESTNET ASSET MANAGEMENT INC, RAYMOND JAMES & ASSOCIATES, and Creative Planning.
This page lists
19
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.